‹ ›
MYP_009184
← PREVIOUS NEXT → BACK
Basic Information
TAT-Cd0
Antimicrobial
Antiviral
Antiviral ▸ Anti-Herpesvirus ▸ Anti-HSV
Antiviral ▸ Anti-HIV
Antiviral ▸ Anti-Influenza virus ▸ Anti-Influenza
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition
Delivery / Targeting ▸ Cell penetration ▸ Cell-penetrating peptide
Delivery / Targeting ▸ Drug delivery vehicle
Enzyme modulation ▸ Enzyme inhibition ▸ Infection inhibition
Standard
11 amino acids
C58H114N32O13S
Standard
Sequence
GRKKRRQRRRC
Physicochemical Analysis
1499.80 Da
12.00
7.75
7.53
0.7044
-3.29
0.49
-1.66
212.45
0.00
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
820.85
-11.09
34.0
22.0
57.0
104.0
0.0
11.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0191380 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
Amidation
Bio-Activity Profile
Antiviral
Exert antiviral activity by virus inactivation
9.5 μM
EC50
Mammalian: 30 h; Yeast: >20 h; E. coli: >10 h
PaperA cationic TAT peptide inhibits Herpes simplex virus type 1 infection of human corneal epithelial cells. | Larsen IV, Brandt CR. | J Ocul Pharmacol Ther. 2010 Dec;26(6):541-7. | DOI:10.1089/jop.2010.0076 | PMID:21029018 PMID21029018 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21029018/
RECORD: Rec_0203811 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
Amidation
Bio-Activity Profile
Antiviral Anti-HSV Infection inhibition
Herpes simplex virus type 1(HSV-1)
0.2 μM
EC50
Mammalian: 30 h; Yeast: >20 h; E. coli: >10 h
PaperA cationic TAT peptide inhibits Herpes simplex virus type 1 infection of human corneal epithelial cells. | Larsen IV, Brandt CR. | J Ocul Pharmacol Ther. 2010 Dec;26(6):541-7. | DOI:10.1089/jop.2010.0076 | PMID:21029018 PMID21029018 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21029018/
RECORD: Rec_0226630 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial Antiviral
Evidence URLhttps://patents.google.com/patent/US7432045B2/en PatentUS 7432045 B2
RECORD: Rec_0259914 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Broad-spectrum antiviral peptide
32630.0
Structure & Mods
synthetic linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Antiviral Anti-HIV Anti-HSV Anti-Influenza
HSV, HIV, Influenza A Virus, H5 Avian Influenza Virus
PaperMethod of inhibiting influenza infection with antiviral peptides Evidence URLhttps://patents.google.com/patent/US7432045B2/en PatentUS 7432045 B2
RECORD: Rec_0351512 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
Amidation
Bio-Activity Profile
Antimicrobial Antiviral
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/
FIRST PREV 1 2 3 NEXT LAST
Showing 5 records on this page · Page 2 of 3